로딩 중…
지수 로딩 중…
원바이오젠
307280· KOSDAQ· Health Care· Health Care Equipment & Services
₩5,680-2.07%
2026-06-19
Price Chart
원바이오젠+1.97%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 40.30B KRW |
| Revenue | 36.27B KRW |
| Net Income | 7.08B KRW |
| Total Assets | 49.65B KRW |
| Net Assets | 41.96B KRW |
| Employees | 72 |
| Value | |
| P/E | 5.69x |
| P/B | 0.96x |
| PEG | 0.11x |
| P/S | 1.11x |
| EV/EBITDA | 4.14x |
| FCF Yield | 11.86% |
| Profitability | |
| ROE | 16.86% |
| ROA | 14.25% |
| Op. Margin | 23.47% |
| Revenue Growth | 12.43% |
| Earnings Growth | 49.74% |
| Financial Health | |
| Debt Ratio | 118.32% |
| Total Debt | 3.50B KRW |
| FCF | 4.78B KRW |
| Cash | 8.56B KRW |
| Current Ratio | 4.31x |
| Net Debt/EBITDA | -0.59x |
| Dividend | |
| Div. Yield | 2.41% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | 1.97% |
| 1M Return | -17.44% |
| From 52W High | -32.38% |
| 1Y MDD | -31.15% |
| Trading | |
| Volume | 21,536 shares |
| Foreign Own. | 3.30% |
| Per Share | |
| EPS | 976 KRW |
| BPS | 6,141 KRW |
Company Info
The company, established in 2006, was listed on the KOSDAQ market in 2021 through a reverse merger with Kyobo 8th Special Purpose Acquisition Company. It manufactures medical materials, wound dressings, biosensor patches, and cosmetics, primarily supplying polyurethane foam dressings and hydrocolloid dressings to hospitals and pharmacies. Driven by population aging and increasing plastic surgeries, the company is expanding its business into the wound dressing market and developing skin regeneration and functional cosmetics in the derma-cosmetic sector. WonBiogen was established in 2018 and is headquartered in Gumi-si, Gyeongsangbuk-do.